About Arco Pharma Private Limited
Data last updated:
Arco Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 March 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1983PTC029602. Its GSTIN is 27AAACA5378A1ZZ (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹75 Lakh. It is led by directors including Amichand Punamchand Jain and Rakesh Kumar Amichand Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 60/70 Ranvir Building 2nd Floor Room No.15 Princess Street, Mumbai, Maharashtra, India – 400002.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.11 Cr. For the same year it recorded a net profit of ₹15.1 Lakh (net margin 1%) and EBITDA of ₹60.78 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 21% over five years.
The company has about 11 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹2.06 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website arcopharmaindia.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address60/70 Ranvir Building 2nd Floor Room No.15 Princess Street, Mumbai, Maharashtra, India – 400002
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Arco Pharma Private Limited
The main business activity of Arco Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Arco Pharma Private Limited FY 2025 filings available
Arco Pharma Private Limited reported revenue of ₹15.11 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR) of Arco Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Arco Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹60.78 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹15.1 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Arco Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Arco Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Arco Pharma Private Limited
Arco Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amichand Punamchand Jain | Director | 22 Mar 1983 | 43 Years 7 Months | Current |
| Rakesh Kumar Amichand Jain | Director | 01 Apr 2001 | 25 Years 6 Months | Current |
| Kalpesh Amichand Jain | Director | 17 Feb 2025 | 1 Years 8 Months | Current |
Peer Comparison of Arco Pharma Private Limited
Arco Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| DVR Pharma LLP | ₹15.2 Cr (FY 2021) | •••• | •••• | 94.0% | •••• | Nalgonda, Telangana, India |
| National Capsules Private Limited | ₹15.19 Cr (FY 2024) | •••• | •••• | -39.0% | •••• | Vidisha, Madhya Pradesh, India |
| Shiv Shakti Pharma Care Private Limited | ₹15.19 Cr (FY 2025) | •••• | •••• | -49.0% | •••• | Vapi, Gujarat, India |
| Nicosia Biolabs International Private Limited | ₹15.16 Cr (FY 2024) | •••• | •••• | 66.0% | •••• | Ludhiana, Punjab, India |
| Eumark Pharmaceuticals Pvt Ltd | ₹15.13 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Ambernath, Maharashtra, India |
| Arco Pharma Private Limited this company | ₹15.11 Cr (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Virjo Pharma and Chemicals Limited | ₹15.08 Cr (FY 2025) | •••• | •••• | -43.0% | •••• | Indore, Madhya Pradesh, India |
| Amba Pigments & Chemicals Private Limited | ₹15.08 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Delhi, India |
| Coax Bioremedies Private Limited | ₹15.08 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Haryana, India |
| Elion Healthcare Private Limited | ₹15.06 Cr (FY 2025) | •••• | •••• | 66.0% | •••• | Vijayawada, Andhra Pradesh, India |
| Kras Pharmaceuticals Private Limited | ₹15.05 Cr (FY 2025) | •••• | •••• | 45.0% | •••• | Fatuha, Bihar, India |
Peers are the five companies nearest above and the five nearest below Arco Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Arco Pharma Private Limited
Arco Pharma Private Limited is audited by RAJMAL JAIN & COMPANY for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJMAL JAIN & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Arco Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Arco Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2011 | Others | ₹99 Lakh | Satisfied |
| 13 Oct 2011 | Others | ₹99 Lakh | Satisfied |
| 13 May 1991 | Bank of Baroda | ₹4 Lakh | Satisfied |
| 13 May 1991 | Bank of Baroda | ₹4 Lakh | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Arco Pharma Private Limited
Arco Pharma Private Limited has 3 court cases on record: 2 filed by Arco Pharma, 1 filed against it. All cases are disposed. Status as checked between 29 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Kerala | Revision petition | Filed by the company against State of Kerala | Disposed |
| District court, Ernakulam, Kerala | Company petition | Filed against the company by an individual | Disposed |
| High Court of Rajasthan | Court case (CRLR) | Filed by the company against State | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Arco Pharma Private Limited
Arco Pharma Private Limited has a workforce of 11 employees as of Mar 29, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Arco Pharma Private Limited
Arco Pharma Private Limited has 4 board changes on record since 1983: 3 appointments and 1 cessation. The latest: Kalpesh Amichand Jain ceased to be Additional Director on 29 Sep 2025.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Arco Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Arco Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Arco Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Arco Pharma Private Limited
Arco Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACA5378A1ZZ | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Arco Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arco Pharma Private Limited
Arco Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 March 1983 (43+ years old) and is registered under CIN U24230MH1983PTC029602.
Arco Pharma reported revenue of ₹15.11 Cr for FY 2025.
Arco Pharma has 3 current directors:
- Amichand Punamchand Jain - Director
- Rakesh Kumar Amichand Jain - Director
- Kalpesh Amichand Jain - Director
Arco Pharma reported a net profit of ₹15.1 Lakh (net margin 1%) and EBITDA of ₹60.78 Lakh (EBITDA margin 4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Arco Pharma is 13% over three years and 21% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Arco Pharma is 27AAACA5378A1ZZ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Arco Pharma is U24230MH1983PTC029602. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arco Pharma has 3 court cases on record: 2 filed by the company and 1 filed against it. Most are in the high courts.
Arco Pharma was incorporated on 22 March 1983, making it 43+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Arco Pharma by revenue are DVR Pharma LLP, National Capsules Private Limited, Shiv Shakti Pharma Care Private Limited, Nicosia Biolabs International Private Limited, Eumark Pharmaceuticals Pvt Ltd and 5 more, all in the Pharma industry (Formulations).
Kalpesh Amichand Jain ceased to be Additional Director on 29 Sep 2025. Kalpesh Amichand Jain was appointed as Director on 17 Feb 2025. Rakesh Kumar Amichand Jain was appointed as Director on 01 Apr 2001. Arco Pharma has 4 board changes on record in total.